Paramount Global Class B (PARA) Stock Price Today
Key Stats
- $7.68BMarket Cap
- -Volume
- MediaSector
- $13.3052W High
- $9.9852W Low
- -Typical Hold Time
- $20.45BEnterprise Value
- 1.81%Div Yield
- -Trading Activity
Track Paramount Global Class B (PARA) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Paramount Global Class B has traded between a low of $9.98 and a high of $13.3, highlighting its annual price range. Buy and sell Paramount Global Class B shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Paramount Global Class B
Paramount Global is the rebranded recombination of CBS and Viacom that has created a media conglomerate with global scale. CBS contributed Showtime in addition to its television assets--the CBS television network, 28 local TV stations, and 50% of CW, a joint venture between CBS and WarnerMedia. Viacom brought several leading cable network properties, including Nickelodeon, MTV, BET, Comedy Central, VH1, CMT, and Paramount. Paramount Pictures produces original motion pictures and owns a library of 2,500 films, including the Mission: Impossible and Transformers series. Paramount operates a number of streaming services, most notably Paramount+ and Pluto TV.
Most Recent News
Gold's biggest headwind from rising real yields may be over, setting stage for recovery.
Gold has faced strong pressure in 2026 due to rising real interest rates increasing the opportunity cost of holding non-yielding gold. However, analysts like BCA Research suggest that real yields may have peaked, meaning the worst impact on gold pric...
OpenAI halts work on Astra model after it shows risky cybersecurity capabilities.
OpenAI has paused development on its upcoming AI model Astra after internal tests revealed it could independently execute cyberattacks on secure systems, triggering the company's cybersecurity safeguards. This move follows a recent incident where ano...
Medline stock drops over 19% after FDA cites major manufacturing violations and lowers earnings forecast.
Medline Inc. faced significant FDA violations related to manufacturing quality, including failure to investigate contamination and cleaning issues, leading to a stock drop of over 7% initially. The stock further fell by more than 12% following disapp...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.